Stephen G Rostand

Summary

Affiliation: University of Alabama at Birmingham
Country: USA

Publications

  1. ncbi Racial disparities in the association of foetal growth retardation to childhood blood pressure
    Stephen G Rostand
    Division of Nephrology, University of Alabama at Birmingham, 1530 3rd Avenue South, Birmingham, AL 35294, USA
    Nephrol Dial Transplant 20:1592-7. 2005
  2. ncbi Racial differences in renal arteriolar structure in children with minimal change nephropathy
    Stephen G Rostand
    Nephrology Research and Training Center, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama 35223, USA
    Kidney Int 68:1154-60. 2005
  3. ncbi Introduction to Vitamin D Symposium, March 14, 2008
    Stephen G Rostand
    Division of Nephrology, University of Alabama at Birmingham, AL 35294, USA
    Clin J Am Soc Nephrol 3:1534. 2008
  4. ncbi Vitamin D, blood pressure, and African Americans: toward a unifying hypothesis
    Stephen G Rostand
    The Nephrology Research and Training Center, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
    Clin J Am Soc Nephrol 5:1697-703. 2010
  5. ncbi The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension
    Janice Lea
    Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
    Arch Intern Med 165:947-53. 2005
  6. ncbi Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial
    Jackson T Wright
    Case Western Reserve University, Department of Medicine, University Hospitals of Cleveland and the Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, OH 44106 5014, USA
    JAMA 288:2421-31. 2002
  7. ncbi Oligonephronia, primary hypertension and renal disease: 'is the child father to the man?'
    Stephen G Rostand
    Nephrol Dial Transplant 18:1434-8. 2003
  8. ncbi The rationale and design of the AASK cohort study
    Lawrence J Appel
    Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, Maryland, 21205, USA
    J Am Soc Nephrol 14:S166-72. 2003
  9. ncbi Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans
    Lawrence J Appel
    Welch Center for Prevention, Epidemiology, and Clinical Research, The Johns Hopkins Institutions, Johns Hopkins University, Baltimore, MD 21205 2223, USA
    Arch Intern Med 168:832-9. 2008

Detail Information

Publications9

  1. ncbi Racial disparities in the association of foetal growth retardation to childhood blood pressure
    Stephen G Rostand
    Division of Nephrology, University of Alabama at Birmingham, 1530 3rd Avenue South, Birmingham, AL 35294, USA
    Nephrol Dial Transplant 20:1592-7. 2005
    ..For this reason we re-examined the role of FGR in childhood blood pressure...
  2. ncbi Racial differences in renal arteriolar structure in children with minimal change nephropathy
    Stephen G Rostand
    Nephrology Research and Training Center, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama 35223, USA
    Kidney Int 68:1154-60. 2005
    ..The aim of this study was to determine if renal vascular changes were more pronounced in African Americans, were independent of blood pressure, and occurred in early childhood...
  3. ncbi Introduction to Vitamin D Symposium, March 14, 2008
    Stephen G Rostand
    Division of Nephrology, University of Alabama at Birmingham, AL 35294, USA
    Clin J Am Soc Nephrol 3:1534. 2008
    ....
  4. ncbi Vitamin D, blood pressure, and African Americans: toward a unifying hypothesis
    Stephen G Rostand
    The Nephrology Research and Training Center, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
    Clin J Am Soc Nephrol 5:1697-703. 2010
    ....
  5. ncbi The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension
    Janice Lea
    Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
    Arch Intern Med 165:947-53. 2005
    ..CONCLUSIONS: The change in the level of proteinuria is a predictor of subsequent progression of hypertensive kidney disease at a given GFR. A prospective trial is needed to confirm this observation...
  6. ncbi Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial
    Jackson T Wright
    Case Western Reserve University, Department of Medicine, University Hospitals of Cleveland and the Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, OH 44106 5014, USA
    JAMA 288:2421-31. 2002
    ..Hypertension is a leading cause of end-stage renal disease (ESRD) in the United States, with no known treatment to prevent progressive declines leading to ESRD...
  7. ncbi Oligonephronia, primary hypertension and renal disease: 'is the child father to the man?'
    Stephen G Rostand
    Nephrol Dial Transplant 18:1434-8. 2003
  8. ncbi The rationale and design of the AASK cohort study
    Lawrence J Appel
    Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, Maryland, 21205, USA
    J Am Soc Nephrol 14:S166-72. 2003
    ..Such results might eventually lead to new strategies that delay or prevent ESRD...
  9. ncbi Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans
    Lawrence J Appel
    Welch Center for Prevention, Epidemiology, and Clinical Research, The Johns Hopkins Institutions, Johns Hopkins University, Baltimore, MD 21205 2223, USA
    Arch Intern Med 168:832-9. 2008
    ..A low blood pressure (BP) goal (BP, <130/80 mm Hg) is also recommended. The objective of this study was to determine the long-term effects of currently recommended BP therapy in 1094 African Americans with hypertensive CKD...